Stablecoins are rapidly emerging as a serious competitor to traditional payment networks like Visa. Over the past month, the 30-day average stablecoin transaction volume has quietly surpassed Visa’s, signaling growing adoption of crypto payments and on-chain dollars.

Australia-based Propanc Biopharma announced it secured up to $100 million in funding from Hexstone Capital to build a crypto treasury and accelerate development of its lead cancer therapy PRP, which targets metastatic solid tumors. The private placement, structured as convertible preferred stock, includes an initial $1 million with up to $99 million available over the next 12 months.

Japan-based digital entertainment and blockchain investment firm Gumi has committed $17 million to XRP as part of its strategy to expand into global payment and remittance networks. The company sees Ripple’s XRP Ledger and its underlying token as crucial infrastructure for enabling cross-border payments at scale, particularly given XRP’s established liquidity and presence in financial ecosystems.

When buying assets (Stocks, Cryptocurrency, Real Estate, etc.), an investor will calculate how much they need to spend, thereby calculating whether the investment is worth it and whether they’ll get a good return later.